Surgalign Holdings Overview
Valuation check: SRGA's ROE is 266.63%, above the Healthcare sector average of 22.01%.
Get informed when a big investor buys or sells
+ Follow266.63%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, SRGA shows a ROE of 266.63%. That is above the Healthcare sector average of 22.01%. Scroll down for historical charts and peer comparison views.
The Healthcare sector average ROE is about 22.01%. Surgalign Holdings is at 266.63%, which is higher that average. That is roughly 1111.4% above the sector mean. Use the comparison chart on this page to see how SRGA stacks up against individual peers as well.
Check the historical chart to see whether SRGA's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Surgalign Holdings with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Surgalign Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 266.63%) with ownership activity and broader fundamentals.
The Healthcare average ROE is about 22.01%, while SRGA is at 266.63%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
